Literature DB >> 15303009

Head imaging abnormalities in dihydropyrimidine dehydrogenase deficiency.

G M Enns1, A J Barkovich, A B P van Kuilenburg, M Manning, T Sanger, D R Witt, A H van Gennip.   

Abstract

Dihydropyrimidine dehydrogenase (DPD) deficiency is a rare autosomal recessive disorder of pyrimidine metabolism. Patients may present with a wide range of neurological symptoms during the first years of life. Head imaging abnormalities have been reported only rarely and include diffuse cerebral atrophy and white-matter hyperintensity. The pathogenesis of the white-matter abnormalities is unknown, although environmental factors and altered energy metabolism may be involved. To further understanding of the spectrum of brain abnormalities associated with DPD deficiency, we report a 17-month-old girl, born to a consanguineous Pakistani couple, who had a history of encephalopathy, prolonged hypoventilation, developmental delay and failure to thrive. Head MRI showed prominent sulci and abnormal T2 prolongation in the cerebral white matter and brainstem. Thus, DPD deficiency may feature prominent brain abnormalities involving the cerebral white matter and brainstem. Anoxic stress may have contributed to the clinical presentation and brain findings in this case. In order to define more clearly the contribution of DPD deficiency to the pathogenesis of these MRI abnormalities, we recommend performing detailed analysis of urine pyrimidine metabolites in patients who have such findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303009     DOI: 10.1023/B:BOLI.0000037350.24142.d5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

1.  Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenase deficiency due to homozygosity for the C29R mutation.

Authors:  A B Van Kuilenburg; P Vreken; D Riva; G Botteon; N G Abeling; H D Bakker; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

2.  MRI in Leigh syndrome with SURF1 gene mutation.

Authors:  Mario Savoiardo; Massimo Zeviani; Graziella Uziel; Laura Farina
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

3.  Partial epilepsy in a girl with a symptom-free sister: first two Finnish patients with dihydropyrimidine dehydrogenase deficiency.

Authors:  I Holopainen; K Pulkki; O J Heinonen; K Näntö-Salonen; L Haataja; J Greter; E Holme; A B van Kuilenburg; P Vreken; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

4.  Clinical variability in three Danish patients with dihydropyrimidine dehydrogenase deficiency all homozygous for the same mutation.

Authors:  E Christensen; I Cezanne; S Kjaergaard; H Hørlyk; V Faurholt Pedersen; P Vreken; A B van Kuilenburg; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 5.  Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.

Authors:  A H van Gennip; N G Abeling; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure.

Authors:  André B P van Kuilenburg; Doreen Dobritzsch; Rutger Meinsma; Janet Haasjes; Hans R Waterham; Malgorzata J M Nowaczyk; George D Maropoulos; Guido Hein; Hermann Kalhoff; Jean M Kirk; Holger Baaske; Anne Aukett; John A Duley; Kate P Ward; Ylva Lindqvist; Albert H van Gennip
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

7.  5-FU multifocal inflammatory leukoencephalopathy and dihydropyrimidine dehydrogenase deficiency.

Authors:  D A Franco; H S Greenberg
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

8.  New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?

Authors:  André B P Van Kuilenburg; Alida E M Stroomer; Henk Van Lenthe; Nico G G M Abeling; Albert H Van Gennip
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

9.  Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

Authors:  G D Heggie; J P Sommadossi; D S Cross; W J Huster; R B Diasio
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

10.  Dihydropyrimidine dehydrogenase deficiency. Neurological aspects.

Authors:  J P Braakhekke; W O Renier; F J Gabreëls; R A De Abreu; J A Bakkeren; R C Sengers
Journal:  J Neurol Sci       Date:  1987-03       Impact factor: 3.181

View more
  8 in total

1.  Dihydropyrimidine dehydrogenase deficiency in two malaysian siblings with abnormal MRI findings.

Authors:  Bee Chin Chen; Rowani Mohd Rawi; Rutger Meinsma; Judith Meijer; Raoul C M Hennekam; André B P van Kuilenburg
Journal:  Mol Syndromol       Date:  2014-09-25

Review 2.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

3.  Dihydropyrimidine Dehydrogenase Deficiency: Metabolic Disease or Biochemical Phenotype?

Authors:  M Fleger; J Willomitzer; R Meinsma; M Alders; J Meijer; R C M Hennekam; M Huemer; A B P van Kuilenburg
Journal:  JIMD Rep       Date:  2017-03-09

4.  The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice.

Authors:  Brendan T Keenan; Raymond J Galante; Jie Lian; Lin Zhang; Xiaofeng Guo; Olivia J Veatch; Elissa J Chesler; W Timothy O'Brien; Karen L Svenson; Gary A Churchill; Allan I Pack
Journal:  Curr Biol       Date:  2021-10-14       Impact factor: 10.834

Review 5.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

6.  Dihydropyrimidine Dehydrogenase Deficiency: Homozygosity for an Extremely Rare Variant in DPYD due to Uniparental Isodisomy of Chromosome 1.

Authors:  André B P van Kuilenburg; Judith Meijer; Rutger Meinsma; Belén Pérez-Dueñas; Marielle Alders; Zahurul A Bhuiyan; Rafael Artuch; Raoul C M Hennekam
Journal:  JIMD Rep       Date:  2018-10-23

Review 7.  Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.

Authors:  Marta Fumagalli; Davide Lecca; Maria P Abbracchio; Stefania Ceruti
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

Review 8.  Metabolic Seizures.

Authors:  Mohammed Almannai; Rabah A Al Mahmoud; Mohammed Mekki; Ayman W El-Hattab
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.